BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38266865)

  • 1. HECW1 restrains cervical cancer cell growth by promoting DVL1 ubiquitination and downregulating the activation of Wnt/β-catenin signaling.
    Xu Z; Guo Y; Wang L; Cui J
    Exp Cell Res; 2024 Feb; 435(2):113949. PubMed ID: 38266865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4.
    Lu C; Ning G; Si P; Zhang C; Liu W; Ge W; Cui K; Zhang R; Ge S
    Biochem Cell Biol; 2021 Oct; 99(5):675-681. PubMed ID: 33529121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of FAM83F by c-Myc promotes cervical cancer growth and aerobic glycolysis via Wnt/β-catenin signaling activation.
    Zhang C; Liu L; Li W; Li M; Zhang X; Zhang C; Yang H; Xie J; Pan W; Guo X; She P; Zhong L; Li T
    Cell Death Dis; 2023 Dec; 14(12):837. PubMed ID: 38104106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
    Chen M; Li L; Zheng PS
    Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.
    Liu J; Dong S; Li L; Wang H; Zhao J; Zhao Y
    Cell Signal; 2019 Jun; 58():91-98. PubMed ID: 30849519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HECT (Homologous to the E6-AP Carboxyl Terminus)-Type Ubiquitin E3 Ligase ITCH Attenuates Cardiac Hypertrophy by Suppressing the Wnt/β-Catenin Signaling Pathway.
    Goto J; Otaki Y; Watanabe T; Kobayashi Y; Aono T; Watanabe K; Wanezaki M; Kutsuzawa D; Kato S; Tamura H; Nishiyama S; Arimoto T; Takahashi H; Shishido T; Watanabe M
    Hypertension; 2020 Dec; 76(6):1868-1878. PubMed ID: 33131309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
    Li L; Yang WT; Zheng PS; Liu XF
    Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
    Zhang X; Wang M; Zhang Y; Yang J; Duan W
    Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway.
    Chen Q; Cao HZ; Zheng PS
    Oncotarget; 2014 Oct; 5(19):9092-105. PubMed ID: 25193857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways.
    Chen X; Sun Z; Zhou S; Jiang W; Li J; Song G; Zhu X
    Mol Carcinog; 2023 Aug; 62(8):1147-1162. PubMed ID: 37132991
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wang L; Zhao H; Fang Y; Yuan B; Guo Y; Wang W
    Physiol Genomics; 2023 Jan; 55(1):1-15. PubMed ID: 36314369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/AXIN2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical Cancer.
    Niu Z; Wang F; Lv S; Lv Y; Liu M; Fu L; Yao Y; Wang L; Lin W; Yuan F
    Mol Cell Biol; 2021 Sep; 41(10):e0011521. PubMed ID: 34309414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.
    Zhang K; Song H; Yang P; Dai X; Li Y; Wang L; Du J; Pan K; Zhang T
    Cell Prolif; 2015 Apr; 48(2):249-58. PubMed ID: 25643607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
    Yin H; Gao T; Xie J; Huang Z; Zhang X; Yang F; Qi W; Yang Z; Zhou T; Gao G; Yang X
    Mol Oncol; 2021 Dec; 15(12):3490-3512. PubMed ID: 34288405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling.
    Fu Q; Sun Z; Yang F; Mao T; Gao Y; Wang H
    Cell Mol Biol Lett; 2019; 24():71. PubMed ID: 31889959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golgi Phosphoprotein 3 Promotes Cervical Cancer Progression via Wnt/β-catenin Mediated Epithelial-Mesenchymal Transition.
    Yang H; Ma X; Song B; Wang D; Chai Z
    Ann Clin Lab Sci; 2023 Sep; 53(5):738-748. PubMed ID: 37945014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP14 promotes the proliferation of cervical cancer via upregulating β-catenin.
    Song H; Qiu J; Hua K
    Environ Toxicol; 2024 Feb; 39(2):1031-1043. PubMed ID: 38069565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/β-catenin signaling in cervical cancer.
    Yu X; Li Z; Bai R; Tang F
    Bioengineered; 2022 May; 13(5):12516-12531. PubMed ID: 35587604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.